2190 — Zylox-Tonbridge Medical Technology Co Balance Sheet
0.000.00%
Last trade - 00:00
- HK$7.87bn
- HK$6.67bn
- CNY527.75m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 98.1 | 317 | 2,929 | 1,861 | 1,511 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8.74 | 6.5 | 5.33 | 12.4 | 13.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 125 | 370 | 3,024 | 2,063 | 1,717 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 70.7 | 122 | 212 | 338 | 578 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 207 | 504 | 3,248 | 3,254 | 3,376 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 33.4 | 51.6 | 97.1 | 152 | 318 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 41.4 | 79.3 | 104 | 160 | 328 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 166 | 425 | 3,145 | 3,094 | 3,047 |
Total Liabilities & Shareholders' Equity | 207 | 504 | 3,248 | 3,254 | 3,376 |
Total Common Shares Outstanding |